Source: BioPortfolio

BlackThorn: Blackthorn Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250

SummaryBlackthorn Therapeutics Inc Blackthorn Therapeutics is a clinicalstage biopharmaceutical company which discovers and develops novel targeted treatments for neurobehavioral disorders. The company is building pipeline of small molecule modulates which...

Read full article »
BlackThorn's Competitors | BlackThorn's News | BlackThorn's Financials
Stay up-to-date with the latest news on BlackThorn
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
William J Martin's photo - President & CEO of BlackThorn

President & CEO

William J Martin

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on BlackThorn